Technical aspects of positron emission tomography/computed tomography in radiotherapy treatment planning

Paola G. Scripes, Ravindra Yaparpalvi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The usage of functional data in radiation therapy (RT) treatment planning (RTP) process is currently the focus of significant technical, scientific, and clinical development. Positron emission tomography (PET) using ( 18F) fluorodeoxyglucose is being increasingly used in RT planning in recent years. Fluorodeoxyglucose is the most commonly used radiotracer for diagnosis, staging, recurrent disease detection, and monitoring of tumor response to therapy (Lung Cancer 2012;76:344-349; Lung Cancer 2009;64:301-307; J Nucl Med 2008;49:532-540; J Nucl Med 2007;48:58S-67S). All the efforts to improve both PET and computed tomography (CT) image quality and, consequently, lesion detectability have a common objective to increase the accuracy in functional imaging and thus of coregistration into RT planning systems. In radiotherapy, improvement in target localization permits reduction of tumor margins, consequently reducing volume of normal tissue irradiated. Furthermore, smaller treated target volumes create the possibility of dose escalation, leading to increased chances of tumor cure and control. This article focuses on the technical aspects of PET/CT image acquisition, fusion, usage, and impact on the physics of RTP. The authors review the basic elements of RTP, modern radiation delivery, and the technical parameters of coregistration of PET/CT into RT computerized planning systems.

Original languageEnglish (US)
Pages (from-to)283-288
Number of pages6
JournalSeminars in Nuclear Medicine
Volume42
Issue number5
DOIs
StatePublished - Sep 2012

Fingerprint

Radiotherapy
Lung Neoplasms
Therapeutics
Neoplasms
Physics
Fluorodeoxyglucose F18
Positron-Emission Tomography
Positron Emission Tomography Computed Tomography
Radiation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Technical aspects of positron emission tomography/computed tomography in radiotherapy treatment planning. / Scripes, Paola G.; Yaparpalvi, Ravindra.

In: Seminars in Nuclear Medicine, Vol. 42, No. 5, 09.2012, p. 283-288.

Research output: Contribution to journalArticle

@article{7f6c76a04b5745339b1eed6d30a43c32,
title = "Technical aspects of positron emission tomography/computed tomography in radiotherapy treatment planning",
abstract = "The usage of functional data in radiation therapy (RT) treatment planning (RTP) process is currently the focus of significant technical, scientific, and clinical development. Positron emission tomography (PET) using ( 18F) fluorodeoxyglucose is being increasingly used in RT planning in recent years. Fluorodeoxyglucose is the most commonly used radiotracer for diagnosis, staging, recurrent disease detection, and monitoring of tumor response to therapy (Lung Cancer 2012;76:344-349; Lung Cancer 2009;64:301-307; J Nucl Med 2008;49:532-540; J Nucl Med 2007;48:58S-67S). All the efforts to improve both PET and computed tomography (CT) image quality and, consequently, lesion detectability have a common objective to increase the accuracy in functional imaging and thus of coregistration into RT planning systems. In radiotherapy, improvement in target localization permits reduction of tumor margins, consequently reducing volume of normal tissue irradiated. Furthermore, smaller treated target volumes create the possibility of dose escalation, leading to increased chances of tumor cure and control. This article focuses on the technical aspects of PET/CT image acquisition, fusion, usage, and impact on the physics of RTP. The authors review the basic elements of RTP, modern radiation delivery, and the technical parameters of coregistration of PET/CT into RT computerized planning systems.",
author = "Scripes, {Paola G.} and Ravindra Yaparpalvi",
year = "2012",
month = "9",
doi = "10.1053/j.semnuclmed.2012.04.006",
language = "English (US)",
volume = "42",
pages = "283--288",
journal = "Seminars in Nuclear Medicine",
issn = "0001-2998",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Technical aspects of positron emission tomography/computed tomography in radiotherapy treatment planning

AU - Scripes, Paola G.

AU - Yaparpalvi, Ravindra

PY - 2012/9

Y1 - 2012/9

N2 - The usage of functional data in radiation therapy (RT) treatment planning (RTP) process is currently the focus of significant technical, scientific, and clinical development. Positron emission tomography (PET) using ( 18F) fluorodeoxyglucose is being increasingly used in RT planning in recent years. Fluorodeoxyglucose is the most commonly used radiotracer for diagnosis, staging, recurrent disease detection, and monitoring of tumor response to therapy (Lung Cancer 2012;76:344-349; Lung Cancer 2009;64:301-307; J Nucl Med 2008;49:532-540; J Nucl Med 2007;48:58S-67S). All the efforts to improve both PET and computed tomography (CT) image quality and, consequently, lesion detectability have a common objective to increase the accuracy in functional imaging and thus of coregistration into RT planning systems. In radiotherapy, improvement in target localization permits reduction of tumor margins, consequently reducing volume of normal tissue irradiated. Furthermore, smaller treated target volumes create the possibility of dose escalation, leading to increased chances of tumor cure and control. This article focuses on the technical aspects of PET/CT image acquisition, fusion, usage, and impact on the physics of RTP. The authors review the basic elements of RTP, modern radiation delivery, and the technical parameters of coregistration of PET/CT into RT computerized planning systems.

AB - The usage of functional data in radiation therapy (RT) treatment planning (RTP) process is currently the focus of significant technical, scientific, and clinical development. Positron emission tomography (PET) using ( 18F) fluorodeoxyglucose is being increasingly used in RT planning in recent years. Fluorodeoxyglucose is the most commonly used radiotracer for diagnosis, staging, recurrent disease detection, and monitoring of tumor response to therapy (Lung Cancer 2012;76:344-349; Lung Cancer 2009;64:301-307; J Nucl Med 2008;49:532-540; J Nucl Med 2007;48:58S-67S). All the efforts to improve both PET and computed tomography (CT) image quality and, consequently, lesion detectability have a common objective to increase the accuracy in functional imaging and thus of coregistration into RT planning systems. In radiotherapy, improvement in target localization permits reduction of tumor margins, consequently reducing volume of normal tissue irradiated. Furthermore, smaller treated target volumes create the possibility of dose escalation, leading to increased chances of tumor cure and control. This article focuses on the technical aspects of PET/CT image acquisition, fusion, usage, and impact on the physics of RTP. The authors review the basic elements of RTP, modern radiation delivery, and the technical parameters of coregistration of PET/CT into RT computerized planning systems.

UR - http://www.scopus.com/inward/record.url?scp=84864407372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864407372&partnerID=8YFLogxK

U2 - 10.1053/j.semnuclmed.2012.04.006

DO - 10.1053/j.semnuclmed.2012.04.006

M3 - Article

C2 - 22840594

AN - SCOPUS:84864407372

VL - 42

SP - 283

EP - 288

JO - Seminars in Nuclear Medicine

JF - Seminars in Nuclear Medicine

SN - 0001-2998

IS - 5

ER -